Bluejay Diagnostics, Inc. stockholders at the June 9, 2026 annual meeting approved an amendment to the 2021 Stock Plan to increase the number of shares reserved for issuance by 600,000. Stockholders also approved an amendment to the certificate of incorporation to authorize a reverse stock split of between 1-for-2 and 1-for-20, with the board of directors to determine the final ratio and timing (no later than June 9, 2027) at its discretion. Bluejay Diagnostics, Inc. is a diagnostics company.
